Clinical heterogeneity in patients with the hypermobility type of Ehlers-Danlos Syndrome

Research in Developmental Disabilities

Volumn 34, Issue 3, 2013, Pages 873-881

  De Wandele, Inge ^a   Rombaut, Lies ^a   Malfait, Fransiska ^b   De Backer, Tine ^c   De Paepe, Anne ^b   Calders, Patrick ^a  

^a GHENT UNIVERSITY   (Belgium)

^b GHENT UNIVERSITY HOSPITAL   (Belgium)

^c GHENT UNIVERSITY   (Belgium)

Author keywords

Clinical heterogeneity; Ehlers Danlos syndrome; Functional impairment; Hypermobility; Non musculoskeletal symptoms; Pain experience

Indexed keywords

ADULT; AGE DISTRIBUTION; ARTHRALGIA; ARTHRITIS; ARTICLE; BLURRED VISION; BURSITIS; CLINICAL FEATURE; CLUSTER ANALYSIS; CONSTIPATION; DAILY LIFE ACTIVITY; DIARRHEA; DISEASE SEVERITY; DIZZINESS; DYSPHAGIA; DYSPHONIA; DYSPNEA; EDUCATIONAL STATUS; EHLERS DANLOS SYNDROME; EMPLOYMENT STATUS; EXERCISE TOLERANCE; FAINTNESS; FATIGUE; FEMALE; FUNCTIONAL STATUS; HEADACHE; HEALTH DISPARITY; HEART PALPITATION; HUMAN; IMMUNE DEFICIENCY; JOINT DISLOCATION; JOINT LAXITY; JOINT SWELLING; LEISURE; MAJOR CLINICAL STUDY; MALE; MARRIAGE; MUSCLE CRAMP; MUSCLE WEAKNESS; MYALGIA; NAUSEA AND VOMITING; ORTHOSTATIC INTOLERANCE; PAIN ASSESSMENT; PHENOTYPIC VARIATION; PHOTOSENSITIVITY DISORDER; PHYSICAL ACTIVITY; PREVALENCE; SEX DIFFERENCE; SKIN DISEASE; SKIN FRAGILITY; SLEEP DISORDER; SOCIAL PSYCHOLOGY; SUBLUXATION; SWEAT GLAND DISEASE; SYMPTOMATOLOGY; TENDINITIS; WOUND HEALING IMPAIRMENT;

ADOLESCENT; ADULT; AGED; CLUSTER ANALYSIS; EHLERS-DANLOS SYNDROME; FATIGUE; FEMALE; GASTROINTESTINAL DISEASES; HUMANS; MALE; MIDDLE AGED; ORTHOSTATIC INTOLERANCE; PAIN; PAIN MEASUREMENT; REGRESSION ANALYSIS; SICKNESS IMPACT PROFILE; SKIN DISEASES; YOUNG ADULT;

EID: 84871948118     PISSN: 08914222     EISSN: 18733379     Source Type: Journal    
DOI: 10.1016/j.ridd.2012.11.018     Document Type: Article

References (32)

1. Beighton P., De Paepe A., Steinmann B., Tsipouras P., Wenstrup R.J. Ehlers-Danlos syndromes: revised nosology, Villefranche, 1997. American Journal of Medical Genetics 1998, 77:31-37.
2. Bergner M., Bobbitt R.A., Carter W.B., Gilson B.S. The Sickness Impact Profile: development and final revision of a health status measure. Medical Care 1981, 19:787-805.
3. Castori M., Camerota F., Celletti C., Danese C., Santilli V., Saraceni V.M., et al. Natural history and manifestations of the hypermobility type Ehlers-Danlos syndrome: a pilot study on 21 patients. American Journal of Medical Genetics Part A 2010, 152A:556-564.
4. Chwalow A.J., Lurie A., Bean K., Parent du Chatelet I., Venot A., Dusser D., et al. A French version of the Sickness Impact Profile (SIP): stages in the cross cultural validation of a generic quality of life scale. Fundamental & Clinical Pharmacology 1992, 6:319-326.
5. Friedman E.M., Irwin M.R. Modulation of immune cell function by the autonomic nervous system. Pharmacology & Therapeutics 1997, 74:27-38.
6. Gazit Y., Nahir A.M., Grahame R., Jacob G. Dysautonomia in the joint hypermobility syndrome. The American Journal of Medicine 2003, 115:33-40.
7. Grahame R. Hypermobility: an important but often neglected area within rheumatology. Nature Clinical Practice Rheumatology 2008, 4:522-524.
8. Hakim A.J., Grahame R. Non-musculoskeletal symptoms in joint hypermobility syndrome. Indirect evidence for autonomic dysfunction?. Rheumatology 2004, 43:1194-1195.
9. Holaday J.W. Cardiovascular effects of endogenous opiate systems. Annual Review of Pharmacology and Toxicology 1983, 23:541-594.
10. Jacobs H.M., Luttik A., Touw-Otten F.W., de Melker R.A. The sickness impact profile; results of an evaluation study of the Dutch version. Nederlands tijdschrift voor geneeskunde 1990, 134:1950-1954.
11. Kerns R.D., Turk D.C., Rudy T.E. The West Haven-Yale Multidimensional Pain Inventory (WHYMPI). Pain 1985, 23:345-356.
12. Kollensperger M., Stampfer-Kountchev M., Seppi K., Geser F., Frick C., Del S.F., et al. Progression of dysautonomia in multiple system atrophy: a prospective study of self-perceived impairment. European Journal of Neurology 2007, 14:66-72.
13. Laliberte S., Lamoureux J., Sullivan M.J., Miller J.M., Charron J., Bouthillier D. French translation of the Multidimensional Pain Inventory: L'inventaire multidimensionnel de la douleur. Pain research & Management 2008, 13:497-505.
14. Levy, H. (2004). Ehlers-Danlos Syndrome, Hypermobility Type. GeneReviews, Updated 14.12.12.
15. Lousberg R., Van Breukelen G.J., Groenman N.H., Schmidt A.J., Arntz A., Winter F.A. Psychometric properties of the Multidimensional Pain Inventory. Behaviour Research and Therapy 1999, 37:167-182.
16. Maeland S., Assmus J., Berglund B. Subjective health complaints in individuals with Ehlers-Danlos syndrome: a questionnaire study. International Journal of Nursing Studies 2011, 48:720-724.
17. Panchal S.J., Muller-Schwefe P., Wurzelmann J.I. Opioid-induced bowel dysfunction: prevalence, pathophysiology and burden. International Journal of Clinical Practice 2007, 61:1181-1187.
18. Remvig L., Engelbert R.H., Berglund B., Bulbena A., Byers P.H., Grahame R., et al. Need for a consensus on the methods by which to measure joint mobility and the definition of norms for hypermobility that reflect age, gender and ethnic-dependent variation: is revision of criteria for joint hypermobility syndrome and Ehlers-Danlos syndrome hypermobility type indicated?. Rheumatology 2011, 50:1169-1171.
19. Rombaut L., Malfait F., Cools A., De Paepe A., Calders P. Musculoskeletal complaints, physical activity and health-related quality of life among patients with the Ehlers-Danlos syndrome hypermobility type. Disability and Rehabilitation 2010, 32:1339-1345.
20. Rombaut L., Malfait F., De Wandele I., Cools A., Thijs Y., De P.A., et al. Medication, surgery, and physiotherapy among patients with the hypermobility type of Ehlers-Danlos syndrome. Archives of Physical Medicine and Rehabilitation 2011, 92:1106-1112.
21. Rombaut L., Malfait F., De P.A., Rimbaut S., Verbruggen G., De Wandele I., et al. Impairment and impact of pain in female patients with Ehlers-Danlos syndrome: a comparative study with fibromyalgia and rheumatoid arthritis. Arthritis and Rheumatism 2011, 63:1979-1987.
22. Romesburg H.C. Qualitative resemblance coefficients. Cluster analysis for researchers 2004, 142-153. Lulu Press, North Carolina. H.C. Romesburg (Ed.).
23. Rowe P.C., Barron D.F., Calkins H., Maumenee I.H., Tong P.Y., Geraghty M.T. Orthostatic intolerance and chronic fatigue syndrome associated with Ehlers-Danlos syndrome. The Journal of Pediatrics 1999, 135:494-499.
24. Smith H., Bruckenthal P. Implications of opioid analgesia for medically complicated patients. Drugs & Aging 2010, 27:417-433.
25. Tinkle B.T., Bird H.A., Grahame R., Lavallee M., Levy H.P., Sillence D. The lack of clinical distinction between the hypermobility type of Ehlers-Danlos syndrome and the joint hypermobility syndrome (a.k.a. hypermobility syndrome). American Journal of Medical Genetics Part A 2009, 149A:2368-2370.
26. van D.N., Boer M.C., Mulder B.J., van Montfrans G.A., Wieling W. Is fatigue in Marfan syndrome related to orthostatic intolerance?. Clinical Autonomic Research 2008, 18:187-193.
27. Van Gestel A.J., Kohler M., Steier J., Teschler S., Russi E.W., Teschler H. Cardiac autonomic dysfunction and health-related quality of life in patients with chronic obstructive pulmonary disease. Respirology 2011, 16:939-946.
28. Verbraecken J., Declerck A., Van de Heyning P., De Backer W., Wouters E.F. Evaluation for sleep apnea in patients with Ehlers-Danlos syndrome and Marfan: a questionnaire study. Clinical Genetics 2001, 60:360-365.
29. Voermans N.C., Knoop H., Bleijenberg G., van Engelen B.G. Pain in Ehlers-Danlos syndrome is common, severe, and associated with functional impairment. Journal of Pain and Symptom Management 2010, 40:370-378.
30. Voermans N.C., Knoop H., van de Kamp N., Hamel B.C., Bleijenberg G., van Engelen B.G. Fatigue is a frequent and clinically relevant problem in Ehlers-Danlos syndrome. Seminars in Arthritis and Rheumatism 2010, 40:267-274.
31. World Health Organization. (2012). WHO's pain ladder. (06.07.12). http://www.who.int/cancer/palliative/painladder/en/.
32. Zweers M.C., Bristow J., Steijlen P.M., Dean W.B., Hamel B.C., Otero M., et al. Haploinsufficiency of TNXB is associated with hypermobility type of Ehlers-Danlos syndrome. American Journal of Human Genetics 2003, 73:214-217.